{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:55:53Z","timestamp":1790657753368,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Changzhou Sci&Tech Program","award":["CJ20242002"],"award-info":[{"award-number":["CJ20242002"]}]},{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"publisher","award":["320.6750.2024-06-71"],"award-info":[{"award-number":["320.6750.2024-06-71"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetes Ther"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s13300-026-01910-3","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T06:43:02Z","timestamp":1787640182000},"page":"1537-1558","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antidiabetic Treatment Intensity and Diabetic Peripheral Neuropathy in a County-Level Metabolic Management Center: A Real-World Cross-Sectional Study"],"prefix":"10.1007","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1291-6188","authenticated-orcid":false,"given":"W. J.","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4086-7177","authenticated-orcid":false,"given":"Jue","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"issue":"1","key":"1910_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41582-024-01041-y","volume":"21","author":"MG Savelieff","year":"2024","unstructured":"Savelieff MG, Elafros MA, Viswanathan V, et al. The global and regional burden of diabetic peripheral neuropathy. Nat Rev Neurol. 2024;21(1):17\u201331. https:\/\/doi.org\/10.1038\/s41582-024-01041-y.","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"1910_CR2","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/s0025-6196(11)61474-2","volume":"81","author":"CE Argoff","year":"2006","unstructured":"Argoff CE, Cole B, Fishbain DA, et al. Diabetic peripheral neuropathic pain: clinical and quality-of-life issues. Mayo Clin Proc. 2006;81(4):S3\u201311. https:\/\/doi.org\/10.1016\/s0025-6196(11)61474-2.","journal-title":"Mayo Clin Proc"},{"key":"1910_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115723","volume":"215","author":"M Kaur","year":"2023","unstructured":"Kaur M, Misra S, Swarnkar P, et al. Understanding the role of hyperglycemia and the molecular mechanism associated with diabetic neuropathy and possible therapeutic strategies. Biochem Pharmacol. 2023;215:115723. https:\/\/doi.org\/10.1016\/j.bcp.2023.115723.","journal-title":"Biochem Pharmacol"},{"issue":"10","key":"1910_CR4","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/s1474-4422(22)00188-0","volume":"21","author":"MA Elafros","year":"2022","unstructured":"Elafros MA, Andersen H, Bennett D, et al. Towards prevention of diabetic peripheral neuropathy: clinical presentation, pathogenesis, and new treatments. Lancet Neurol. 2022;21(10):922\u201336. https:\/\/doi.org\/10.1016\/s1474-4422(22)00188-0.","journal-title":"Lancet Neurol"},{"issue":"5","key":"1910_CR5","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.2337\/db19-1046","volume":"69","author":"BH Braffett","year":"2020","unstructured":"Braffett BH, Gubitosi-Klug R, Albers JW, et al. Risk factors for diabetic peripheral neuropathy and cardiovascular autonomic neuropathy in the diabetes control and complications trial\/epidemiology of diabetes interventions and complications (DCCT\/EDIC) study. Diabetes. 2020;69(5):1000\u201310. https:\/\/doi.org\/10.2337\/db19-1046.","journal-title":"Diabetes"},{"issue":"12","key":"1910_CR6","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1007\/s13300-024-01658-8","volume":"15","author":"S Beshyah","year":"2024","unstructured":"Beshyah S, Jayyousi A, Al-Mamari A, et al. Current perspectives in pre- and diabetic peripheral neuropathy diagnosis and management: an expert statement for the Gulf region. Diabetes Ther. 2024;15(12):2455\u201374. https:\/\/doi.org\/10.1007\/s13300-024-01658-8.","journal-title":"Diabetes Ther"},{"issue":"9","key":"1910_CR7","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s00592-020-01518-4","volume":"57","author":"X Wang","year":"2020","unstructured":"Wang X, Zhao W, Ke J, et al. Comparison and analyses of therapeutic effects between metabolic management center (MMC) and conventional management modes. Acta Diabetol. 2020;57(9):1049\u201356. https:\/\/doi.org\/10.1007\/s00592-020-01518-4.","journal-title":"Acta Diabetol"},{"issue":"6","key":"1910_CR8","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/1753-0407.13290","volume":"14","author":"J Liu","year":"2022","unstructured":"Liu J, Bloomgarden ZT. The Chinese metabolic management centers. J Diabetes. 2022;14(6):362\u20134. https:\/\/doi.org\/10.1111\/1753-0407.13290.","journal-title":"J Diabetes"},{"issue":"24","key":"1910_CR9","doi-asserted-by":"publisher","first-page":"11859","DOI":"10.3390\/ijms262411859","volume":"26","author":"A Mitrea","year":"2025","unstructured":"Mitrea A, \u0218tefan AG, Vladu IM, et al. A composite score of insulin resistance and inflammation biomarkers for predicting lower limb complications in type 2 diabetes mellitus. Int J Mol Sci. 2025;26(24):11859. https:\/\/doi.org\/10.3390\/ijms262411859.","journal-title":"Int J Mol Sci"},{"issue":"Suppl 1","key":"1910_CR10","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.2337\/dc20-S002","volume":"43","author":"American Diabetes Association","year":"2020","unstructured":"American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2020. Diabetes Care. 2020;43(Suppl 1):S14\u201331. https:\/\/doi.org\/10.2337\/dc20-S002.","journal-title":"Diabetes Care"},{"key":"1910_CR11","doi-asserted-by":"publisher","first-page":"4191","DOI":"10.2147\/dmso.s482824","volume":"17","author":"Y Tang","year":"2024","unstructured":"Tang Y, Zhang P, Li L, et al. Diabetic peripheral neuropathy and glycemia risk index in type 2 diabetes: a cross-sectional study. Diabetes Metab Syndrome Obes. 2024;17:4191\u20138. https:\/\/doi.org\/10.2147\/dmso.s482824.","journal-title":"Diabetes Metab Syndrome Obes"},{"issue":"2","key":"1910_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0212574","volume":"14","author":"X Liu","year":"2019","unstructured":"Liu X, Xu Y, An M, et al. The risk factors for diabetic peripheral neuropathy: a meta-analysis. PLoS ONE. 2019;14(2):e0212574. https:\/\/doi.org\/10.1371\/journal.pone.0212574.","journal-title":"PLoS ONE"},{"issue":"3","key":"1910_CR13","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3390\/medicina62030451","volume":"62","author":"MS Popoviciu","year":"2026","unstructured":"Popoviciu MS, Ghitea TC, Panti\u0219 C, et al. Determinants of HbA1c variability across clinical subgroups: when the same value does not reflect the same biological risk. Medicina. 2026;62(3):451. https:\/\/doi.org\/10.3390\/medicina62030451.","journal-title":"Medicina"},{"issue":"8","key":"1910_CR14","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.2337\/dc15-0856","volume":"38","author":"KMV Narayan","year":"2015","unstructured":"Narayan KMV, Gujral UP. Evidence tips the scale toward screening for hyperglycemia. Diabetes Care. 2015;38(8):1399\u2013401. https:\/\/doi.org\/10.2337\/dc15-0856.","journal-title":"Diabetes Care"},{"issue":"2","key":"1910_CR15","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1370\/afm.240176","volume":"23","author":"M Khazen","year":"2025","unstructured":"Khazen M, Shalev L, Golan-Cohen A, et al. Teamwork among primary care staff to achieve regular follow-up of chronic patients. Ann Fam Med. 2025;23(2):100\u20137. https:\/\/doi.org\/10.1370\/afm.240176.","journal-title":"Ann Fam Med"},{"issue":"3","key":"1910_CR16","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1053\/j.ajkd.2023.06.001","volume":"82","author":"M Tang","year":"2023","unstructured":"Tang M, Kalim S. Long-term glycemic variability: a variable glycemic metric entangled with glycated hemoglobin. Am J Kidney Dis. 2023;82(3):254\u20136. https:\/\/doi.org\/10.1053\/j.ajkd.2023.06.001.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"1910_CR17","doi-asserted-by":"publisher","first-page":"22276","DOI":"10.1038\/s41598-024-73472-y","volume":"14","author":"KC Chang","year":"2024","unstructured":"Chang KC, Pai YW, Lin CH, et al. Glycemic variability\u2019s impact on painful diabetic peripheral neuropathy in type 2 diabetes patients. Sci Rep. 2024;14(1):22276. https:\/\/doi.org\/10.1038\/s41598-024-73472-y.","journal-title":"Sci Rep"},{"key":"1910_CR18","doi-asserted-by":"publisher","first-page":"204201882513722","DOI":"10.1177\/20420188251372294","volume":"16","author":"SM Khayyat","year":"2025","unstructured":"Khayyat SM, Ali RSA. The role of medication regimen complexity in diabetes management: a rapid review. Therap Adv Endocrinol Metab. 2025;16:20420188251372294. https:\/\/doi.org\/10.1177\/20420188251372294.","journal-title":"Therap Adv Endocrinol Metab"},{"issue":"1","key":"1910_CR19","doi-asserted-by":"publisher","first-page":"13499","DOI":"10.1038\/s41598-023-40752-y","volume":"13","author":"Q He","year":"2023","unstructured":"He Q, Zeng Z, Zhao M, et al. Association between thyroid function and diabetes peripheral neuropathy in euthyroid type 2 diabetes mellitus patients. Sci Rep. 2023;13(1):13499. https:\/\/doi.org\/10.1038\/s41598-023-40752-y.","journal-title":"Sci Rep"},{"issue":"14","key":"1910_CR20","doi-asserted-by":"publisher","first-page":"7755","DOI":"10.2147\/IJGM.S337779","volume":"6","author":"MA Allam","year":"2021","unstructured":"Allam MA, Nassar YA, Shabana HS, et al. Prevalence and clinical significance of subclinical hypothyroidism in diabetic peripheral neuropathy. Int J Gen Med. 2021;6(14):7755\u201361. https:\/\/doi.org\/10.2147\/IJGM.S337779.","journal-title":"Int J Gen Med"},{"issue":"2","key":"1910_CR21","doi-asserted-by":"publisher","first-page":"34","DOI":"10.13078\/jsm.15007","volume":"12","author":"SE Kim","year":"2015","unstructured":"Kim SE, Park BS, Park SH, et al. Predictors for presence and severity of obstructive sleep apnea in snoring patients: significance of neck circumference. J Sleep Med. 2015;12(2):34\u20138. https:\/\/doi.org\/10.13078\/jsm.15007.","journal-title":"J Sleep Med"},{"issue":"6","key":"1910_CR22","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/sj.ijo.0802002","volume":"26","author":"M Laakso","year":"2002","unstructured":"Laakso M, Matilainen V, Kein\u00e4nen-Kiukaanniemi S. Association of neck circumference with insulin resistance-related factors. Int J Obes. 2002;26(6):873\u20135. https:\/\/doi.org\/10.1038\/sj.ijo.0802002.","journal-title":"Int J Obes"},{"issue":"1","key":"1910_CR23","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1186\/1471-2458-14-311","volume":"14","author":"H Li","year":"2014","unstructured":"Li H, Zhang F, Zhao D, et al. Neck circumference as a measure of neck fat and abdominal visceral fat in Chinese adults. BMC Public Health. 2014;14(1):311. https:\/\/doi.org\/10.1186\/1471-2458-14-311.","journal-title":"BMC Public Health"},{"issue":"4","key":"1910_CR24","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s11154-025-09973-6","volume":"26","author":"S Chew","year":"2025","unstructured":"Chew S, Avinashi SD, Venkataraman K. Predictors of incident diabetic peripheral neuropathy: a systematic review of longitudinal studies in patients with diabetes mellitus. Rev Endocr Metab Disord. 2025;26(4):659\u201377. https:\/\/doi.org\/10.1007\/s11154-025-09973-6.","journal-title":"Rev Endocr Metab Disord"},{"key":"1910_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.671257","volume":"12","author":"J Carmichael","year":"2021","unstructured":"Carmichael J, Fadavi H, Ishibashi F, et al. Advances in screening, early diagnosis and accurate staging of diabetic neuropathy. Front Endocrinol. 2021;12:671257. https:\/\/doi.org\/10.3389\/fendo.2021.671257.","journal-title":"Front Endocrinol"}],"container-title":["Diabetes Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-026-01910-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13300-026-01910-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-026-01910-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:14:49Z","timestamp":1790655289000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13300-026-01910-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["1910"],"URL":"https:\/\/doi.org\/10.1007\/s13300-026-01910-3","relation":{},"ISSN":["1869-6953","1869-6961"],"issn-type":[{"value":"1869-6953","type":"print"},{"value":"1869-6961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"assertion":[{"value":"5 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Wenjun Chen, Jie Zhou, and Jue Peng have no relevant financial or non-financial conflicts of interest to disclose in relation to this work.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Biomedical Research Ethics Committee of Liyang People's Hospital (Approval No. 2024023). All procedures were performed in accordance with the 1964 Declaration of Helsinki and its later amendments. The requirement for written informed consent was waived for this retrospective analysis of fully de-identified routine clinical data.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}